Cargando…
Multimodal Metabolic Imaging Reveals Pigment Reduction and Lipid Accumulation in Metastatic Melanoma
Objective and Impact Statement. Molecular signatures are needed for early diagnosis and improved treatment of metastatic melanoma. By high-resolution multimodal chemical imaging of human melanoma samples, we identify a metabolic reprogramming from pigmentation to lipid droplet (LD) accumulation in m...
Autores principales: | Lee, Hyeon Jeong, Chen, Zhicong, Collard, Marianne, Chen, Fukai, Chen, Jiaji G., Wu, Muzhou, Alani, Rhoda M., Cheng, Ji-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AAAS
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521760/ https://www.ncbi.nlm.nih.gov/pubmed/37849907 http://dx.doi.org/10.34133/2021/9860123 |
Ejemplares similares
-
Drugging the Epigenome: Overcoming Resistance to Targeted and Immunotherapies in Melanoma
por: Hanly, Ailish, et al.
Publicado: (2021) -
Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy()
por: Rbah-Vidal, Latifa, et al.
Publicado: (2016) -
The Benefits and Challenges of the Multimodal Treatment in Advanced/Metastatic Malignant Melanoma
por: Stoian, Alexandru-Rares, et al.
Publicado: (2023) -
Tattoo pigment in an axillary lymph node simulating metastatic malignant melanoma
por: Jack, CM, et al.
Publicado: (2005) -
Regression of pigmented lesions in a patient with metastatic melanoma treated with immunotherapy
por: Schwager, Zachary, et al.
Publicado: (2018)